Literature DB >> 22513104

A phantom study to assess accuracy of needle identification in real-time planning of ultrasound-guided high-dose-rate prostate implants.

Matthew Schmid1, Juanita M Crook, Deidre Batchelar, Cynthia Araujo, David Petrik, David Kim, Ross Halperin.   

Abstract

PURPOSE: High-dose-rate brachytherapy of the prostate is commonly performed using transrectal ultrasound (US) guidance, with CT imaging used for needle reconstruction and treatment planning. Transrectal ultrasound images can, however, be used for the entire process, allowing treatment without changes in the patient position. This study assesses needle reconstruction accuracy using US images. METHODS AND MATERIALS: Prostate phantoms were implanted with 10-18 needles. Three-dimensional US images were acquired, and needles were reconstructed using specialized software. A CT scan was also obtained. The image sets were registered and needle reconstruction errors were assessed. A dose plan was obtained using the US images and the dwell times were transferred to the CT reconstruction to obtain the true "delivered dose," which was evaluated using standard dosimetric parameters.
RESULTS: Two sources of error were identified. First, reconstruction based on the bright echoes in the US images introduces a systematic error because these echoes correspond to the proximal wall of the needle, and not the center of the needle channel. If left uncorrected, this shift can lead to an underestimate of urethral doses. Second, incorrect needle tip identification can occur in the cranial-caudal direction. Errors up to 5.8mm were observed. A measurement of needle lengths protruding beyond the template can be used to compensate for this.
CONCLUSIONS: Factors limiting the accuracy of US-based needle reconstruction have been identified. Once recognized, these errors can be corrected for, resulting in accurate implant geometry. This facilitates a treatment technique combining excellent anatomic definition, minimal prostate motion, and accurate dose planning and delivery.
Copyright © 2013 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22513104     DOI: 10.1016/j.brachy.2012.03.002

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  5 in total

1.  Evaluation of transrectal ultrasound-based dosimetry for brachytherapy of prostate cancer: a single-center experience.

Authors:  Changzhao Yang; Zhengtong Lv; Lingxiao Chen; Jie Wang; Xiheng Hu; Harripersaud Chand; Xi Sun; Guyu Tang; Congyi Tang; Huichuan Jiang; Yuan Li
Journal:  J Contemp Brachytherapy       Date:  2020-08-21

2.  Multi-needle Localization with Attention U-Net in US-guided HDR Prostate Brachytherapy.

Authors:  Yupei Zhang; Yang Lei; Richard L J Qiu; Tonghe Wang; Hesheng Wang; Ashesh B Jani; Walter J Curran; Pretesh Patel; Tian Liu; Xiaofeng Yang
Journal:  Med Phys       Date:  2020-04-03       Impact factor: 4.071

3.  Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy.

Authors:  Tonghe Wang; Robert H Press; Matt Giles; Ashesh B Jani; Peter Rossi; Yang Lei; Walter J Curran; Pretesh Patel; Tian Liu; Xiaofeng Yang
Journal:  Br J Radiol       Date:  2019-04-09       Impact factor: 3.039

Review 4.  Review of advanced catheter technologies in radiation oncology brachytherapy procedures.

Authors:  Jun Zhou; Leonid Zamdborg; Evelyn Sebastian
Journal:  Cancer Manag Res       Date:  2015-07-16       Impact factor: 3.989

5.  Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results.

Authors:  Olivier Lauche; Guila Delouya; Daniel Taussky; Cynthia Menard; Dominic Béliveau-Nadeau; Yannick Hervieux; Renée Larouche; Maroie Barkati
Journal:  J Contemp Brachytherapy       Date:  2016-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.